Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
1) FDA to hold two-day meeting on off-label drug marketing. STAT, November 8, 2016.
The FDA will hold a public meeting to review the extent to which off-label information about medicines may be given to physicians.
2) Walgreen Sues Theranos, Seeks $140 Million in Damages. The Wall Street Journal, November 8, 2016.
Walgreen sued its former lab-testing partner, alleging a breach of contract.
3) CMS to pay hospitals to drop coverage appeals. Modern Healthcare, November 7, 2016.
CMS is trying to clear a backlog of Medicare appeals by offering to pay hospitals a portion of denied claims for dropping pending appeals.
4) U.S. watchdog told Medicare, Medicaid that EpiPen was misclassified in 2009: senator. Reuters, November 8, 2016.
EpiPen was improperly classified as a generic drug in 2009.
5) Tenet Healthcare sued for $1.5 billion over tuberculosis exposure. Modern Healthcare, November 8, 2016.
A class action is accusing Tenet of failing to protect patients and newborns from being exposed to tuberculosis.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. CLICK HERE TO SUBSCRIBE.
P.S. If you or your patients are interested in consumer healthcare issues, check out myhealthspin.com.
